Body weight loss is a simple and useful indicator of prognosis and predictive tolerability in the first year of nintedanib therapy in patients with interstitial lung disease

Autor: Yamakawa, Hideaki, Sato, Shintaro, Ohta, Hiroki, Kusano, Kenji, Kawabe, Rie, Oba, Tomohiro, Uzuka, Chisa, Sasaki, Hiroki, Akasaka, Keiichi, Amano, Masako, Takemura, Tamiko, Araya, Jun, Matsushima, Hidekazu
Zdroj: In Respiratory Investigation July 2024 62(4):551-557
Databáze: ScienceDirect